Viral Oncology Therapies

This feed focuses on Viral Oncology Therapies, which exploits the ability of genetically engineered viruses to infect and kill cancer cells. Discover the latest research on Viral Oncology Therapies here.

January 17, 2022

In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide.

Journal of Cancer Research and Clinical Oncology
Tingyu LiXiao Li
January 17, 2022

Multimodal immune activation abilities and characteristics of reovirus.

American Journal of Translational Research
So Yeon KimSanjay Goel
January 15, 2022

Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses.

World Journal of Surgical Oncology
Ali Zarezadeh MehrabadiHadi Esmaeili Gouvarchin Ghaleh
January 15, 2022

Novel group C oncolytic adenoviruses carrying a microRNA inhibitor demonstrate enhanced oncolytic activity in vitro and in vivo.

Molecular Cancer Therapeutics
Johannes DoernerAnja Ehrhardt
January 13, 2022

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.

Journal for Immunotherapy of Cancer
Marilin S KochSean Lawler
January 13, 2022
Open Access

SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability.

Communications Biology
Manami HiraiwaEiichi Hinoi
January 10, 2022

Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma.

Cancer Immunology, Immunotherapy : CII
Robyn D GartrellYvonne M Saenger
January 11, 2022
Open Access

Oncolytic Viruses and Cancer, Do You Know the Main Mechanism?

Frontiers in Oncology
Wesam KootiMasoumeh Bolandian
January 11, 2022
Open Access

Clinical Trials of Oncolytic Viruses in Breast Cancer.

Frontiers in Oncology
Mary E CarterAndreas D Hartkopf
January 6, 2022

Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.

Cellular & Molecular Immunology
Chaohu PanGenhong Cheng
January 5, 2022

Talimogene Laherparepvec in Non-Melanoma Cancers.

The Journal of Clinical and Aesthetic Dermatology
Antoine SalloumNathalie C Zeitouni
January 4, 2022
Open Access

Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Lindsey CarlsenWafik S. El-Deiry
January 4, 2022

Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma.

Methods in Molecular Biology
Sangeet Lal, Corey Raffel
January 4, 2022

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.

Molecular Therapy Oncolytics
Dakota W GoadValery Z Grdzelishvili
January 4, 2022

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory.

Molecular Therapy Oncolytics
Rūta VeinaldeChristine E Engeland
January 4, 2022
Open Access

Immunotherapy Resistance in Glioblastoma.

Frontiers in Genetics
Elaina J WangManish K Aghi
January 3, 2022
Open Access

A Glimpse in the Future of Malignant Mesothelioma Treatment.

Frontiers in Pharmacology
Gaetano PezzicoliCamillo Porta
December 31, 2021
Open Access

Apoptosis During ZIKA Virus Infection: Too Soon or Too Late?
Jonathan TurpinPascale Krejbich-Trotot

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

© 2022 Meta ULC. All rights reserved